MEDP | Dr. Jon Bragi Bjarnason Appointed To MedSpas Advisory Board

Penny Stocks
Jul 25, 2008 1:00:00 PM

ATLANTA, GA -- (MARKET WIRE) -- 07/25/08 -- Medspas of America Inc. (PINKSHEETS: MEDP),, announced today that Dr. Jon Bragi Bjarnason, Chief Executive Officer and Founder of Zymetech Inc.,, has joined the Company's Advisory Board.

Dr. Bjarnason discovered a highly active marine enzyme off the coast of Iceland that is now known as Penzim. After extensive research on the marine enzyme's wound healing capabilities, Dr. Bjarnason received the worldwide patent for Penzim, the trade name of this enzyme and the main ingredient in Natural Renu's anti-aging product line.

Dr. Bjarnason is a Professor of Biochemistry at the University of Iceland and has served as Chairman, Department of Chemistry, University of Iceland; Chairman, Science Institute, University of Iceland; Visiting Professor, Department of Biochemistry, Colorado State University; Visiting Professor, Department of Microbiology, and is currently a Visiting Professor at the University of Virginia Medical School.

Dr. Bjaranson holds a Bachelor of Science in Chemistry from the University of Iceland and a Ph.D. in Biochemistry from Colorado State University, Fort Collins, Colorado. Dr, Bjarnason has received a fellowship from the Alexander von Humbolt Foundation and a fellowship from NATO.